← Leaderboards
Deborah M Anderson
University Of Missouri-Columbia
$5,225,128
Attributed
$5,340,808
Total exposure
8
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $836.2K · FY2007–24$1M$750K$500K$250K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$5,340,808 · 8
By mechanism
R21$1,964,329 · 5
R01$1,837,104 · 1
U54$1,539,375 · 2
Top collaborators
- Wendy L Picking1 shared
Most similar at University Of Missouri-Columbia
Same institution · by research overlap
- Wendy L Picking$15,895,808
- Haval Shirwan$11,979,492
Others in their field
Top investigators on “Infection”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,939,185
- Lawrence Corey · Fred Hutchinson Cancer Center$789,608,171
- Judith S. Currier · University Of California Los Angeles$511,038,212
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$463,711,983
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$415,229,497
Research focus
InfectionLaboratoriesYersinia PestisPlaguePathogenPathogenesisBacteriaGrowthInvestigationMouse ModelPneumonic PlagueImmune ResponseAntibiotic TherapyResponseVirulenceEventMortalityPathway InteractionsBubonic PlagueImmunityPhenotypeHuman DiseasePandemic DiseaseImmune
Grant awards (22)
Transovarial transmission of yersinia pestis in fleas$227,054
R21 · FY2024 · AI · contact PI
Targeting T3SA proteins as protective antigens against Yersinia$231,360
R21 · FY2023 · AI
Transovarial transmission of yersinia pestis in fleas$186,974
R21 · FY2023 · AI · contact PI
Host Response and Immunity to Yersenia pestis Infection$365,222
R01 · FY2021 · AI · contact PI
Host Response and Immunity to Yersenia pestis Infection$365,705
R01 · FY2020 · AI · contact PI
Host Response and Immunity to Yersenia pestis Infection$366,176
R01 · FY2019 · AI · contact PI
Development of a Host Targeted Therapeutic for Pneumonic Plague$217,106
R21 · FY2019 · AI · contact PI
Host Response and Immunity to Yersenia pestis Infection$366,637
R01 · FY2018 · AI · contact PI
Development of a Host Targeted Therapeutic for Pneumonic Plague$180,684
R21 · FY2018 · AI · contact PI
Host Response and Immunity to Yersenia pestis Infection$373,364
R01 · FY2017 · AI · contact PI
RBL-Innate Immunity Core$98,374
U54 · FY2013 · AI · contact PI
RBL-Innate Immunity Core$216,299
U54 · FY2012 · AI · contact PI
RBL-Innate Immunity Core$261,823
U54 · FY2011 · AI · contact PI
RBL-Innate Immunity Core$269,606
U54 · FY2010 · AI · contact PI
Regulation of Yersenia pestis virulence genes in response to host cell contact$221,032
R21 · FY2010 · AI · contact PI
RBL-Innate Immunity Core$506,310
U54 · FY2009 · AI · contact PI
Regulation of Yersenia pestis virulence genes in response to host cell contact$183,751
R21 · FY2009 · AI · contact PI
Development of Novel Genetic Tools for Metabolic Selection in Yersinia Pestis$129,963
R21 · FY2009 · AI · contact PI
Development of Novel Genetic Tools for Metabolic Selection in Yersinia Pestis$16,206
R21 · FY2009 · AI · contact PI
Therapeutic Intervention of Pneumonic Plague by Monoclonal Antibodies to LcrV$186,963
U54 · FY2008 · AI · contact PI
Development of Novel Genetic Tools for Metabolic Selection in Yersinia Pestis$183,324
R21 · FY2008 · AI · contact PI
Development of Novel Genetic Tools for Metabolic Selection in Yersinia Pestis$186,875
R21 · FY2007 · AI · contact PI